Categories Earnings, Retail

G-III Apparel Group (GIII): Q3 2020 Earnings Snapshot

— G-III Apparel Group Ltd. (NASDAQ: GIII) reported its third-quarter 2020 adjusted earnings of $1.99 per share versus $1.94 per share expected.

— Net sales rose by 5% to $1.13 billion versus $1.17 billion expected. The company maintained good momentum in its wholesale business, in spite of the challenging retail and macro environment.

Earnings Update by AlphaStreet

— Looking ahead into fiscal 2020, the company lowered its net sales outlook to about $3.20 billion from the previous estimate of about $3.30 billion. This is compared to the consensus estimates of $3.28 billion.

— The earnings guidance is reduced to the range of $3.01-3.11 per share from the prior range of $3.10-3.20 per share for the full year.

— The adjusted earnings forecast is cut to the range of $3.06-3.16 from the previous range of $3.15-3.25 per share for fiscal 2020. This is compared to the analysts’ expectations of $3.16 per share.

— The company projects fiscal 2020 adjusted EBITDA in the range of $283-288 million compared to adjusted EBITDA of $269.4 million in fiscal 2019.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

BLK Earnings: BlackRock Q2 2024 profit jumps on higher revenues

Asset management company BlackRock, Inc. (NYSE: BLK) on Monday reported a double-digit increase in adjusted profit for the second quarter of 2024, aided by an 8% increase in revenues. Second-quarter

GS Earnings: All you need to know about Goldman Sachs’ Q2 2024 earnings results

The Goldman Sachs Group, Inc. (NYSE: GS) reported its second quarter 2024 earnings results today. Net revenues were $12.73 billion, up 17% compared to the same period a year ago,

Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024

Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth. The medical device maker is thriving on the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top